News and reflections from the world of AI

Faron Pharmaceuticals utilizes AI to perform spatial analysis in cancer drug development research

In cancer patients, the immune system's ability to recognize and destroy cancer cells is often suppressed due to several factors. Cancer cells can ...

Written by Aiforia

The benefits of digital pathology in education

Digital pathology refers to using digital imaging technology to acquire, manage, and analyze high-resolution digital images of pathological ...

Written by Aiforia

Women in STEM: Hande Demir Holopainen

How long have you been at Aiforia, and what do you do? I’ve worked at Aiforia for over a year as a Project Specialist on the Science team. My main ...

Written by Aiforia

April 27, 2023

Aiforia has received a funding decision from Business Finland to accelerate the development of AI-assisted software solutions for clinical pathology and drug development

Aiforia Technologies Plc, Company release, 27 April 2023 at 12:00 a.m. EEST. Aiforia has received a funding decision from Business Finland to accelerate the development of AI-assisted software solutions for clinical pathology and drug development.

Written by Aiforia

April 4, 2023

First NHS Trust has signed a contract to adopt Aiforia PD-L1 AI model for lung cancer in clinical diagnostics

Aiforia Technologies Plc, Press Release, 04 April 2023 at 12:00 a.m. EEST. The first NHS Trust of the PathLAKE Plus consortium has signed an individual contract to adopt Aiforia PD-L1 AI model for lung cancer in clinical diagnostics. The duration of the contract is three years, with a possible three-year extension.

Written by Aiforia

March 10, 2023

Aiforia Technologies Plc appoints Vice President of Marketing

Aiforia Technologies Plc appoints a new Vice President of Marketing who brings international experience in various commercial positions both in the field of tissue diagnostics and targeted therapies for cancer.

Written by Aiforia